Navigation Links
Purolite Corporation to Develop Bioseparation Resins Based on Agarose Media
Date:10/21/2013

BALA CYNWYD, Pa., Oct. 21, 2013 /PRNewswire/ -- Purolite announced today that it will develop bioseparation resins for chromatography based on agarose media that will be manufactured in their cGMP, FDA regulated facility. The new line will expand the LifeTech™ family of products to cover the SEC, HIC, IEX and affinity bio-purification media for the fast-growing biomolecules market.

The new products will launch in 2014 and support a range of customer needs from drug development with pre-packed columns to bulk media for industrial production of biomolecules. Standard and customized products will be available for the agarose product line. All Purolite products go through rigorous application testing.

"The Life science industry has been dominated for a long time by a few major producers as well as small niche companies," stated Dr. Alessandra Basso, Purolite LifeTech Manager. "With decades of critical application experience and a global, knowledgeable technical sales team dedicated to high-level service, Purolite is positioned to provide bioseparation resins that meet the most stringent demands for biotechnological research and applications."

About Purolite

Purolite Corporation is a leading manufacturer of ion exchange media, catalysts, adsorbents and advanced polymers. Headquartered in Bala Cynwyd, Pa., the company has ISO 9001 certified manufacturing facilities in the USA, China and Romania and operates dedicated R&D centers in the USA, China, Romania, Russia and the UK. Purolite, the only company focused exclusively on resin technology, has 40 sales offices in more than 30 countries.

Purolite Corporation is also one of the world's largest developers and manufacturers of high-quality APIs, blood purification polymers, enzyme carriers, and chromatographic resins for life sciences.

For further information on resins for bio-chromatography and the LifeTech family of products, visit www.purolite.com.


'/>"/>
SOURCE Purolite Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
2. Kensey Nash Corporation Announces Achievement of $6 Million Milestone From Spectranetics Corporation
3. China Cord Blood Corporation Announces Results of 2011 Annual General Meeting
4. Neogen Corporation Announces 2nd Quarter Results Conference Call
5. Luminex Corporation to Present at JP Morgan Healthcare Conference
6. Luminex Corporation Fourth Quarter and Full Year 2011 Earnings Release Scheduled for February 6, 2012
7. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
8. JBT Corporation and Swisslog Enter Into Partnership for Automated Guided Vehicles
9. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2012
10. Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results
11. Luminex Corporation to Speak at Joint Department of Defense and Environmental Protection Agency 5th National Bio-Threat Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... ... President Andi Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief ... ), Inc. has been selected for membership in ARCS Alumni Hall of ...
(Date:10/11/2017)... ... 2017 , ... ComplianceOnline’s Medical Device Summit is back for its 4th year. ... San Francisco, CA. The Summit brings together current and former FDA office bearers, regulators, ... government officials from around the world to address key issues in device compliance, quality ...
(Date:10/11/2017)... Netherlands and LAGUNA HILLS, Calif. ... Institute of Cancer Research, London (ICR) ... MMprofilerâ„¢ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with ... known as MUK nine . The University of ... which is partly funded by Myeloma UK, and ICR will ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
Breaking Biology Technology:
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
Breaking Biology News(10 mins):